Breast Neoplasms Clinical Trials

31 studies are recruiting for breast neoplasms in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies, page 2

1. Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

   The main purpose of this study is to compare genetic markers present on tumor cells before and after chemotherapy.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Washington University School of Medicine, St Louis, Missouri

   Run by

   Washington University School of Medicine

   See if you can join NCT00353483 on ClinicalTrials.gov

2. DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment

   To prospectively evaluate the efficacy and safety of DPYD-guided dosing strategies in a real-world clinical setting, specifically by comparing the incidence of severe (Grade 3 and 4) fluoropyrimidine-related toxicities of heterozygous DPYD variant patients assigned to DPYD-guided reduced dosing ver…

   Stage

   Phase 4

   Ages

   18 and older

   Site

   RWJBarnabas Health Clara Maas Medical Center, Belleville, New Jersey

   Locations

   12 in total

   Run by

   Rutgers, The State University of New Jersey

   See if you can join NCT07158164 on ClinicalTrials.gov

3. Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM

   TROPION-DM/BrUOG-431 is a prospective, , phase 2 trial with two non-comparative cohorts analyzed jointly for primary endpoint in adult patients with either (Cohort 1:) advanced/metastatic hormone-receptor positive ([HR+], estrogen receptor and/or progesterone receptor positive) breast cancer (BC), …

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Rhode Island and the Miriam Hospitals (Brown University Health), Providence, Rhode Island

   Run by

   Brown University

   See if you can join NCT06974604 on ClinicalTrials.gov

4. The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy

   This study will determine how the intestinal microbiome differs between patients with obesity and early triple-negative breast cancer who achieve a pathologic complete response from preoperative anti-PD-1 immunotherapy (pembrolizumab) versus patients who do not.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Pennington Biomedical Research Center, Baton Rouge, Louisiana

   Run by

   Pennington Biomedical Research Center

   See if you can join NCT06318507 on ClinicalTrials.gov

5. Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer

   This is a prospective, registry study that will enroll all women with early stage breast cancer who will be treated with intraoperative radiotherapy (IORT) during breast-conserving surgery. The purpose of this study is to further validate the long-term effectiveness and safety of this treatment met…

   Stage

   Not phased

   Ages

   18 and older

   Site

   John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica, California

   Run by

   Saint John's Cancer Institute

   See if you can join NCT04603209 on ClinicalTrials.gov

6. Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ

   The trial aims to investigate the use of superparamagnetic iron oxide (SPIO) nanoparticles as a tracer for delayed sentinel lymph node dissection (d-SLND) in patients where upfront axillary surgery (SLND) is oncologically deemed unnecessary and should be avoided. This includes but is not limited to…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Baylor College Of Medicine, Houston, Texas

   Locations

   9 in total

   Run by

   Uppsala University

   See if you can join NCT04722692 on ClinicalTrials.gov